No Diagnostic Criteria, No Treatment Guidelines, Twenty Men to Every Woman

It starts as small bumps at the back of the neck, at the hairline, where the hair is shortest. They look like ingrown hairs or razor bumps and are frequently treated as such for years. Over time they coalesce into firm, raised plaques, the hair inside them is destroyed permanently, and the result is a band of scar tissue across the occipital scalp that does not grow hair again.

It is called acne keloidalis nuchae, which is doubly misleading — it is not acne, and the lesions are not true keloids.

StatPearls, the standard reference on the condition, puts the male to female ratio at roughly 20:1, and describes it as most common in darkly pigmented skin, especially in African American men.

Now the prevalence figure, which is where this gets embarrassing for the field. A systematic estimate carried in a British Journal of Dermatology supplement puts it at between 0.45 percent and 13.6 percent of all dermatoses in individuals of African descent.

A range spanning a factor of thirty is not an estimate. It is an admission that the underlying studies are heterogeneous case series that cannot be pooled, and that nobody has run the population study.

The literature does not stop with Black men

There is a multicenter retrospective cohort of 142 Hispanic patients with acne keloidalis nuchae, published in Dermatology Practical & Conceptual.

A hundred and forty-two patients is a substantial series for this condition, and its existence directly contradicts the framing in most of the teaching material, which treats AKN as a condition of African-descent men specifically. A Hispanic man presenting with occipital bumps is, on that framing, not a candidate for the diagnosis, which is exactly how a treatable early-stage condition becomes an untreatable scarred one.

The treatment evidence, and the numbers it will not carry

The treatment evidence is better than the epidemiology, which is not a high bar.

Laser is the strongest modality. Long-pulsed 1064 nm Nd:YAG and 810 nm diode are the devices with reported outcomes, over courses of roughly one to five sessions. The mechanism is straightforward — destroy the follicles that are generating the inflammation, and the inflammation stops.

The improvement percentages attached to those devices travel everywhere and trace nowhere. I cannot point you to the report they came from, so I am not going to print them as though somebody measured them. Same for the lesion-reduction and recurrence figures quoted for multimodal surgery: that surgical disease recurs is established and belongs in the consent conversation, but the percentage does not, until there is a series to attach it to.

Intralesional triamcinolone reduces lesion size and carries a risk of hypopigmentation and atrophy — a meaningful trade-off in skin where a pale depressed patch on the neck is its own problem.

Isotretinoin, from Gamil and colleagues in 2018, has an anti-inflammatory effect on the folliculitis component at moderate dose but does not affect the indurated fibrotic lesions. Which means it may help early and does nothing for what is already scarred — an argument for early intervention rather than an argument against the drug.

And the British Journal of Dermatology source underneath much of this states outright that no universal diagnostic criteria or treatment guidelines exist for the condition. Not that they are contested. That they have not been written. A field with no agreed definition is also a field with no agreed denominator, which is why its efficacy numbers float free of any study you can open.

The window

This is a scarring condition, and everything about how it should be managed follows from that.

Small papules at the nape that come and go are the reversible stage. Firm confluent plaques with hairless skin are not. The distance between those two states is measured in years, and the years are usually spent being treated for razor bumps — which is a reasonable mistake, because that is exactly what the early stage looks like, and because the two conditions share a mechanism in short hairs and mechanical irritation.

Things that make it worse and are worth removing from the equation early: close clipping at the nape, particularly with a razor over the hairline; tight collars and caps that rub the occipital scalp; and continued shaving of an area that is already inflamed.

If bumps at the back of the neck have been coming back for more than a year, the question to put to a clinician is not how to clear them. It is whether this is acne keloidalis nuchae, and whether laser is appropriate now rather than after there is a plaque to treat.

The difference between those two appointments is the difference between hair that grows back and a band of scar that does not, and nothing in the literature will tell you how long you have.

This article is educational and is not a substitute for care from someone who can look at your skin. Anything new, changing, painful or spreading should be assessed rather than researched.